glp-1 agonists oral new glp 1 agonist In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron New GLP-1 Guidelines for Type

By route of administration type, the oral segment is expected to show the highest growth during the predicted time

adults had used a GLP-1 agonist

Wajdlich, M

Inability to consume adequate calories despite dietary strategies

Beyond drug development and manufacturing, there are adjacent opportunities in packaging and distribution channels including online pharmacies (eg Numan, Hims and Hers) and digital health platforms

Access and Availability Issues: Medication Shortages The Problem: Mounjaro frequently out of stock at pharmacies Cant start or continue treatment consistently Shortages interrupt weight loss progress No guarantee when supply will return The Solution: Alternative sources may have better availability, including compounded options that arent subject to the same shortage issues